DexCom
DXCM
#946
Rank
NZ$44.02 B
Marketcap
NZ$114.09
Share price
2.27%
Change (1 day)
-22.19%
Change (1 year)

EPS for DexCom (DXCM)

EPS in 2026 (TTM): NZ$4.11

According to DexCom's latest financial reports the company's current EPS (TTM) is NZ$4.11. In 2025 the company made an earnings per share (EPS) of NZ$3.68 an increase over its 2024 EPS that were of NZ$2.52.

EPS history for DexCom from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$4.1111.52%
2025NZ$3.6846.26%
2024NZ$2.524.26%
2023NZ$2.4260.23%
2022NZ$1.5166.82%
2021NZ$0.90
2019NZ$0.47-175.69%
2018NZ-$0.62144.07%
2017NZ-$0.25-24.36%
2016NZ-$0.336.85%
2015NZ-$0.31143.33%
2014NZ-$0.13

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.97 264.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.18 50.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
NZ$6.15 49.58%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Becton Dickinson
BDX
NZ$9.36 127.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Edwards Lifesciences
EW
NZ$3.24-21.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
NZ-$5.26-227.92%๐Ÿ‡บ๐Ÿ‡ธ USA
QuidelOrtho
QDEL
NZ-$28.55-794.17%๐Ÿ‡บ๐Ÿ‡ธ USA
West Pharmaceutical Services
WST
NZ$12.89 213.33%๐Ÿ‡บ๐Ÿ‡ธ USA